Inhaled Low‐Dose Iloprost for Pulmonary Hypertension: A Prospective, Multicenter, Open‐Label Study

BACKGROUND: Inhaled iloprost (average >30 µg/d) has been considered an effective treatment for severe pulmonary hypertension (PH). Further evidence also showed that low‐dose iloprost given intravenously was equally effective as high‐dose iloprost in the therapy of systemic sclerosis. HYPOTHESIS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Sun, Yun‐Juan, Xiong, Chang‐Ming, Shan, Guang‐Liang, Gu, Qing, Zeng, Wei‐Jie, Lu, Xian‐Ling, Zhu, Feng, Liu, Zhi‐Hong, Ni, Xin‐Hai, He, Jian‐Guo
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2012
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652663/
https://ncbi.nlm.nih.gov/pubmed/22488211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.21987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados